Page contentsPage contents Key facts Decision Key facts Active substance resiniferatoxin Therapeutic area Musculoskeletal and connective tissue disorders Decision number EMA/PE/0000182440 PIP number EMA/PE/0000182440 Pharmaceutical form(s) Solution for injection Condition(s) / indication(s) Treatment of chronic musculoskeletal pain Route(s) of administration Intra-articular use Contact for public enquiries Grünenthal GmbH Tel. +49 2415690E-mail: pediatrics@grunenthal.com Decision type W: decision granting a waiver in all age groups for all conditions or indications Decision date 06/12/2024 Compliance check done No Decision EMA/PE/0000182440 : EMA decision of 6 December 2024 on the granting of a product specific waiver for resiniferatoxinAdopted Reference Number: EMADOC-1700519818-1790103 English (EN) (240.79 KB - PDF)First published: 09/12/2025 View Share this page